New cystic fibrosis drug made seven-year-old girl feel better within hours

Kate Farrer is one of the first young children to be given Kaftrio on the NHS.

12 February 2022

A child who received a life-changing cystic fibrosis drug has told how she felt better within hours.

Kate Farrer, seven, is one of the first young children to be given Kaftrio on the NHS. Previously, the drug was only available to patients over the age of 12.

However, it has now been extended to the younger age group thanks to a landmark deal done by the NHS in June 2020.

Kate Farrer, right, with her younger sister Orla (Family handout/NHS)

The “modulator” drug benefits lung function, allowing patients to breathe easily and have a better quality of life.

Kate started taking the drug on Sunday, and began to feel an improvement just three hours later, her family said.

She is one of about 1,300 children aged six to 11 who will now be able to access the drug.

Kate said she was “really happy” with the new drug.

“I am really happy because it is a life-changing drug and it is going to help me a lot when I am older.”

She added that she was feeling “a lot better” and can exhale without coughing.

“Now with this new medication – I have only been on it a few days but I am feeling a lot better now – it is really exciting that I got it, because now life will hopefully be a bit fairer with me, because sometimes it is not as fair because of all of my treatment and medications.

“I am actually quite happy as I can now exhale all the way and not cough at all, not one bit.”

More from Perspective

Get a free copy of our print edition


Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.
You need to agree with the terms to proceed

Your email address will not be published. The views expressed in the comments below are not those of Perspective. We encourage healthy debate, but racist, misogynistic, homophobic and other types of hateful comments will not be published.